NIH Exploratory/Developmental Cooperative Agreement Phase I (UH2)
Funds Exploratory/Developmental Cooperative Agreement Phase I awards, NIH's UH2 mechanism.
The National Institutes of Health uses the Exploratory/Developmental Cooperative Agreement Phase I (UH2) to support the development of new research activities in categorical program areas. (Support generally is restricted in level of support and in time.).
NIH files the mechanism under Research and Development.
Each announcement under UH2 sets its own deadline, budget and eligibility. NIH publis…
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.
Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.
Funds analytically and clinically validating a cancer biomarker and its assay for detection, diagnosis, prognosis or treatment response.